Stifel Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.47M Buy
13,700
+6,627
+94% +$2.16M ﹤0.01% 1310
2025
Q1
$1.91M Sell
7,073
-2,944
-29% -$795K ﹤0.01% 1790
2024
Q4
$2.36M Buy
10,017
+4,187
+72% +$985K ﹤0.01% 1650
2024
Q3
$1.6M Sell
5,830
-109
-2% -$30K ﹤0.01% 1918
2024
Q2
$1.44M Sell
5,939
-2,401
-29% -$583K ﹤0.01% 1946
2024
Q1
$1.25M Sell
8,340
-3,318
-28% -$496K ﹤0.01% 2050
2023
Q4
$2.23M Buy
11,658
+3,589
+44% +$687K ﹤0.01% 1588
2023
Q3
$1.43M Sell
8,069
-1,253
-13% -$222K ﹤0.01% 1808
2023
Q2
$1.77M Buy
9,322
+1,611
+21% +$306K ﹤0.01% 1714
2023
Q1
$1.54M Buy
7,711
+261
+4% +$52.3K ﹤0.01% 1743
2022
Q4
$1.77M Sell
7,450
-2,807
-27% -$667K ﹤0.01% 1607
2022
Q3
$2.05M Buy
10,257
+673
+7% +$135K ﹤0.01% 1454
2022
Q2
$1.4M Sell
9,584
-2,592
-21% -$378K ﹤0.01% 1750
2022
Q1
$1.99M Sell
12,176
-2,500
-17% -$408K ﹤0.01% 1617
2021
Q4
$2.49M Buy
14,676
+674
+5% +$114K ﹤0.01% 1462
2021
Q3
$2.64M Sell
14,002
-8,775
-39% -$1.66M ﹤0.01% 1395
2021
Q2
$3.86M Buy
22,777
+2,530
+12% +$429K 0.01% 1157
2021
Q1
$2.86M Buy
20,247
+4,207
+26% +$594K ﹤0.01% 1288
2020
Q4
$2.08M Buy
16,040
+1,310
+9% +$170K ﹤0.01% 1363
2020
Q3
$2.14M Buy
14,730
+1,288
+10% +$187K ﹤0.01% 1179
2020
Q2
$1.99M Buy
13,442
+7,116
+112% +$1.05M ﹤0.01% 1162
2020
Q1
$689K Buy
6,326
+1,639
+35% +$179K ﹤0.01% 1656
2019
Q4
$539K Buy
4,687
+603
+15% +$69.3K ﹤0.01% 2204
2019
Q3
$328K Buy
4,084
+114
+3% +$9.16K ﹤0.01% 2399
2019
Q2
$288K Buy
3,970
+1,496
+60% +$109K ﹤0.01% 2524
2019
Q1
$232K Buy
+2,474
New +$232K ﹤0.01% 2519
2015
Q3
Sell
-3,807
Closed -$456K 2251
2015
Q2
$456K Buy
3,807
+173
+5% +$20.7K ﹤0.01% 1732
2015
Q1
$379K Buy
+3,634
New +$379K ﹤0.01% 1774